The Impact of Metabolic Syndrome on Patients Undergoing Breast Reduction Surgery
| Autor: | Radhika Malhotra, Ramazi O. Datiashvili, Kristin R Riddle, Haripriya S. Ayyala |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Nutrition and Dietetics business.industry Endocrinology Diabetes and Metabolism medicine.medical_treatment 030209 endocrinology & metabolism Surgical procedures medicine.disease Obesity Reduction Mammoplasty Surgery 03 medical and health sciences 0302 clinical medicine medicine 030211 gastroenterology & hepatology In patient Breast reduction Metabolic syndrome business |
| Zdroj: | Obesity Surgery. 30:2434-2436 |
| ISSN: | 1708-0428 0960-8923 |
| Popis: | Metabolic syndrome affects 35% of individuals in the USA and has been correlated with increased complications following certain surgical procedures. There has been an increase of 11% in breast reduction procedures from 2016 to 2017 making it the seventh most common reconstructive procedure in the USA. Previous studies have identified an increase in demand for breast reduction among obese patients with BMI ≥ 30 but have not defined the role of metabolic syndrome in surgical outcomes. The authors aim to investigate the impact of metabolic syndrome on 30-day postoperative morbidity and mortality in patients who underwent reduction mammoplasty. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink